Market Overview:
The global genome editing market is expected to grow at a CAGR of 15.5% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for genetically modified crops and animals, rising prevalence of chronic diseases, and technological advancements in CRISPR-based genome editing tools. However, the high cost of genome editing tools and ethical concerns associated with gene editing may restrain the growth of this market during the forecast period. The global genome Editing Market is segmented on the basis of type, application, and region. On the basis of type, it is divided into CRISPR-based genome editing tools, TALEN-based genome editing tools ZFN-based Genome Editing Tools .On The Basis Of Application , It Is Divided Into Cell Line Engineering Animal Genetic Engineering Plant Genetic Engineering .Regionally , It Is Analyzed In North America Latin America Europe Asia Pacific And Middle East & Africa . Among all regions analyzed North America accounted for maximum share in 2017 due to presence major players such as Thermo Fisher Scientific Inc., Illumina Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Caribou Biosciences Inc.
Product Definition:
Genome editing is the process of manipulating genes in a living organism. This can be done through traditional breeding methods, or by using technology to edit DNA directly. The importance of genome editing lies in its potential to correct genetic defects, improve crops and livestock, and treat diseases.
CRISPR:
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a gene editing tool that enables the modification of any genome with high specificity and efficiency. It is an adaptive immune system for the detection of viral infections. The technology has wide applications in agriculture, animal breeding, biotechnology, food industry and medicine manufacturing among others.
TALEN:
TALEN (Transcription- Activated Lexical Enrichment) is an enzyme that catalyzes the recognition and binding of RNA polymerase to specific sites in DNA. It is used for gene silencing, regulation of chromatin structure, epigenetic modification detection & genome editing. Currently it is being used for the treatment of genetic diseases such as Leber Hereditary Optic Neuropathy (LHON), Hunter syndrome and X-ALD.
Application Insights:
The cell line engineering segment dominated the global market in terms of revenue share in 2017. This is due to its wide application in various fields such as stem cell research, gene therapy, and cancer research. The advent of new technologies has led to an increase in the number of published studies involving genome editing using CRISPR/Cas9 system for genetic modification of cells.
For instance, a study was conducted by researchers at Stanford University School of Medicine and Genome Engineering Institute (GEI) to demonstrate that it is possible to use this technology for efficient editing within human iPSCs (induced Pluripotent Stem Cells). In addition, another study reported the development of a non-viral delivery method called TALENsense for efficient introduction into human somatic cells with minimal off-target effects. Such developments are expected to positively impact the growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of CRISPR/Cas9-based companies and universities, increased funding for genome editing research, and high adoption rate of advanced technologies across this region. Moreover, growing interest in gene editing from researchers working on human health is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing investments by governments as well as private entities in order to improve crop yields using genetic engineering techniques such as TALENs and ZFNs. In addition, rising awareness about genome editing among farmers will boost demand for these products over the next eight years ending note that countries such as China are at forefront when it comes come with their investments related agricultural R&D activities which further drives Asia Pacific market share in terms of revenue generation during same period under consideration here i.e.
Growth Factors:
- Increasing demand for genetically modified crops
- Rising prevalence of genetic disorders
- Growing application of genome editing in biomedical research
- Advances in CRISPR technology
- Increasing investment in genome editing
Scope Of The Report
Report Attributes
Report Details
Report Title
Genome Editing Market Research Report
By Type
CRISPR, TALEN, ZFN
By Application
Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering
By Companies
Genscript, Horizon Discovery Group, Lonza, Merck KGaA, Sangamo Therapeutics, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
188
Number of Tables & Figures
132
Customization Available
Yes, the report can be customized as per your need.
Global Genome Editing Market Report Segments:
The global Genome Editing market is segmented on the basis of:
Types
CRISPR, TALEN, ZFN
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Genscript
- Horizon Discovery Group
- Lonza
- Merck KGaA
- Sangamo Therapeutics
- Thermo Fisher Scientific
Highlights of The Genome Editing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CRISPR
- TALEN
- ZFN
- By Application:
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Genome Editing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Genome editing is a technology that allows scientists to change the sequence of DNA in an organism. This can be done using a variety of methods, including CRISPR-Cas9 and other genome editing tools. Genome editing has the potential to revolutionize research and medicine by allowing scientists to correct genetic defects or diseases in organisms without having to remove them from the population altogether.
Some of the major companies in the genome editing market are Genscript, Horizon Discovery Group, Lonza, Merck KGaA, Sangamo Therapeutics, Thermo Fisher Scientific.
The genome editing market is expected to grow at a compound annual growth rate of 15.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Genome Editing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Genome Editing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Genome Editing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Genome Editing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Genome Editing Market Size & Forecast, 2018-2028
4.5.1 Genome Editing Market Size and Y-o-Y Growth
4.5.2 Genome Editing Market Absolute $ Opportunity
Chapter 5 Global Genome Editing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Genome Editing Market Size Forecast by Type
5.2.1 CRISPR
5.2.2 TALEN
5.2.3 ZFN
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Genome Editing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Genome Editing Market Size Forecast by Applications
6.2.1 Cell Line Engineering
6.2.2 Animal Genetic Engineering
6.2.3 Plant Genetic Engineering
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Genome Editing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Genome Editing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Genome Editing Analysis and Forecast
9.1 Introduction
9.2 North America Genome Editing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Genome Editing Market Size Forecast by Type
9.6.1 CRISPR
9.6.2 TALEN
9.6.3 ZFN
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Genome Editing Market Size Forecast by Applications
9.10.1 Cell Line Engineering
9.10.2 Animal Genetic Engineering
9.10.3 Plant Genetic Engineering
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Genome Editing Analysis and Forecast
10.1 Introduction
10.2 Europe Genome Editing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Genome Editing Market Size Forecast by Type
10.6.1 CRISPR
10.6.2 TALEN
10.6.3 ZFN
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Genome Editing Market Size Forecast by Applications
10.10.1 Cell Line Engineering
10.10.2 Animal Genetic Engineering
10.10.3 Plant Genetic Engineering
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Genome Editing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Genome Editing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Genome Editing Market Size Forecast by Type
11.6.1 CRISPR
11.6.2 TALEN
11.6.3 ZFN
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Genome Editing Market Size Forecast by Applications
11.10.1 Cell Line Engineering
11.10.2 Animal Genetic Engineering
11.10.3 Plant Genetic Engineering
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Genome Editing Analysis and Forecast
12.1 Introduction
12.2 Latin America Genome Editing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Genome Editing Market Size Forecast by Type
12.6.1 CRISPR
12.6.2 TALEN
12.6.3 ZFN
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Genome Editing Market Size Forecast by Applications
12.10.1 Cell Line Engineering
12.10.2 Animal Genetic Engineering
12.10.3 Plant Genetic Engineering
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Genome Editing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Genome Editing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Genome Editing Market Size Forecast by Type
13.6.1 CRISPR
13.6.2 TALEN
13.6.3 ZFN
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Genome Editing Market Size Forecast by Applications
13.10.1 Cell Line Engineering
13.10.2 Animal Genetic Engineering
13.10.3 Plant Genetic Engineering
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Genome Editing Market: Competitive Dashboard
14.2 Global Genome Editing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Genscript
14.3.2 Horizon Discovery Group
14.3.3 Lonza
14.3.4 Merck KGaA
14.3.5 Sangamo Therapeutics
14.3.6 Thermo Fisher Scientific
